Approval · Notice of Compliance 27465 · 2022
FAMPYRA: Notice of Compliance 27465
Issued January 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27465
- Date
- January 25, 2022
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph (PM) with respect to safety and efficacy and to update the PM to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FAMPYRA | Not yet assigned | — |
Medicinal ingredients
- FAMPRIDINE 10 MG per TAB